Cargando…

Demographic, clinical and treatment characteristics of the carra registry systemic JIA cohort

Detalles Bibliográficos
Autores principales:	Janow, Ginger, Schanberg, Laura, Setoguchi, Soko, Mellins, Elizabeth D, Schneider, Rayfel, Kimura, Yukiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184288/ http://dx.doi.org/10.1186/1546-0096-12-S1-P64

Ejemplares similares

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
por: Beukelman, Timothy, et al.
Publicado: (2017)

Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry
por: Ringold, Sarah, et al.
Publicado: (2012)

The swedish paediatric JIA-registry
por: Magnusson, Bo
Publicado: (2014)

Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus
por: Ota, Sylvia, et al.
Publicado: (2008)

Carrà /
por: Carrà, Carlo, 1881-1966
Publicado: (1987)

Understanding the biology and use of anti-TNF agents in JIA – interim results
por: Lovell, Daniel J, et al.
Publicado: (2012)

The childhood arthritis & rheumatology research alliance network registry: demographics and characteristics of the initial 6-month cohort
por: Natter, Marc D, et al.
Publicado: (2012)

MEFV mutations in systemic JIA
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Mesenchymal stem cells and JIA
por: Swart, JF, et al.
Publicado: (2011)

Puberty and disease activity in JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

Clinical classification of JIA in Albania
por: Vula, Aurel, et al.
Publicado: (2014)

Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups
por: Stepanenko, NY
Publicado: (2011)

Determing an “autoimmune” phenotype in systemic JIA
por: Fischer, N, et al.
Publicado: (2011)

Adverse events of methotrexate treatment in JIA
por: in ‘t Veld, J, et al.
Publicado: (2011)

Evaluation of the JIA treatment with adalimumab in ukraine
por: Ponochevna, Elena, et al.
Publicado: (2014)

Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
por: Polat, Adem, et al.
Publicado: (2011)

Understanding the biology and use of TNF therapy in jia-clinical outcomes
por: Lovell, Daniel, et al.
Publicado: (2014)

The effects of early aggressive therapy in JIA: results of the TREAT study
por: Wallace, Carol A, et al.
Publicado: (2012)

Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA)
por: Falcini, FF, et al.
Publicado: (2008)

Inflence of clinical and genetic characteristics on ability to achive and maintain remission in JIA patients on etanercept treatment
por: Lazarevic, Dragana S, et al.
Publicado: (2014)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Use of internet in adolescents and young adults with JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

JIA-like in a boy with Ataxia-telangiectasia
por: Furtado, Filipa, et al.
Publicado: (2014)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

Accuracy of preliminary remission criteria some JIA category
por: Fantini, F, et al.
Publicado: (2008)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
por: Zak, M, et al.
Publicado: (2008)

Neuroblastoma versus systemic JIA – a diagnostic dilemma
por: Scalzi, Lisabeth, et al.
Publicado: (2012)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
por: Morgan DeWitt, Esi M, et al.
Publicado: (2012)

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
por: Kimura, Yukiko, et al.
Publicado: (2017)

The correlation between clinical and ultrasonographic findings of ankle disease in JIA
por: Burns, JFT, et al.
Publicado: (2008)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Are genetic variants of Caspase-1 and Cryopyrin associated with systemic JIA?
por: Stock, CJ, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

Changes in articular cartilage thickness of the knee in JIA as assessed by ultrasonography
por: Pradsgaard, D, et al.
Publicado: (2011)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
por: Officioso, A, et al.
Publicado: (2011)

Evaluation of disease activity in a population of Russian JIA patients
por: Kostareva, OM, et al.
Publicado: (2011)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kti3ed4ojs98qo4ope01lgh3sc